Multicenter trial of olmesartan. Main results

Multicenter trial of olmesartan. Main results

Development and introduction into practice of medicines reducing activity of the renin-angiotensin-aldosteron system the key element of which is angiotensin II (ATII) resulted in a significant improvement of efficacy of cardiovascular diseases treatment. Angiotensin converting enzyme (ACE) inhibitor...

Full description

Bibliographic Details
Main Authors: Fail' Taipovich Ageev, Ol'ga Nikolaevna Svirida, F T Ageev, O N Svirida
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2011-09-01
Series:Терапевтический архив
Subjects:
olmesartan
angiotensin ii receptor blocker
arterial pressure
diabetes mellitus
organ protection
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30927

Internet

https://ter-arkhiv.ru/0040-3660/article/view/30927

Similar Items